BioMarin sNDA seeking full Voxzogo approval accepted by FDA

NDA FilingVoxzogoPositive

AI Analysis

Summary

BioMarin's supplemental NDA seeking full approval for Voxzogo has been accepted by the FDA for review. This regulatory milestone represents progress toward expanded labeling for the drug.

Outcome Details

sNDA seeking full approval accepted by FDA

Importance:6/10

Sentiment:

0.60

regulatoryFDANDAVoxzogo

Related Companies

$BMRN

Read the original article

Published by Seeking Alpha Healthcare on July 13, 2026 4:23 PM

Read Original